Evommune: Funding, Investors & Team (Oct 2026)
Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines for inflammatory diseases.
Evommune has raised $146M across 3 funding rounds on record, the most recent a Series B of $50.0M announced in Apr 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Evommune Company Profile and Key Stats
Latest funding round on record: Apr 2023.
Evommune Funding Rounds
Evommune raised $12.5M in an undisclosed round announced in Nov 2020.
10 months later, a Series A of $83.0M was announced in Sep 2021.
1.6 years later, a Series B of $50.0M was announced in Apr 2023.
Evommune Founders and Leadership Team
Contact details for the Evommune team: 2 of 2 have an email address on file.
Start 14-day free trial →Evommune Funding Compared to Other Biotechnology Startups
Evommune's latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Evommune in Biotechnology and Los Altos
Companies Similar to Evommune
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Evommune Funding FAQs
What does Evommune do?
Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines for inflammatory diseases.
How much funding has Evommune raised?
Evommune has raised $146M across 3 rounds on record. The most recent is a Series B of $50.0M announced in Apr 2023.
When did Evommune last raise funding?
Evommune's most recent funding round on record is a Series B of $50.0M, announced in Apr 2023.
Who founded Evommune?
FundedIQ lists Jamie Harden (Founder) at Evommune.
Who is the CEO of Evommune?
Luis Pena is listed as CEO at Evommune.
Where is Evommune headquartered?
Evommune is based in Los Altos, California, United States.
How many employees does Evommune have?
Evommune is in the 11-50 employee band.
How does Evommune's funding compare to other Biotechnology startups?
Evommune's latest round of $50.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Evommune Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Evommune is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.